Both in Pharmaceuticals
Spruce Biosciences vs Journey Medical
Over the past year SPRB returned −59.1% and DERM returned −45.5%; their daily moves had a correlation of 0.17.
SPRB −59.1% DERM −45.5%Growth of $1, one year, split-adjusted
| Metric | SPRB | DERM |
|---|---|---|
| Price | $42.81 | $4.64 |
| Market cap | $123.0M | $131.0M |
| Today | −3.91% | −3.13% |
| 1 month | −5.7% | −30.6% |
| 6 months | −27.9% | −10.4% |
| Year to date | −50.9% | −39.8% |
| 1 year | −61.1% | −42.9% |
| Revenue growth (YoY) | — | +18.9% |
| Gross margin | — | 65.6% |
| Net margin | — | −1.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.0× |
| Net cash | $89.2M | -$245.0K |
| Dividend yield | — | — |
| Volatility (60d) | 64.5% | 64.3% |
| Short % of float | 22.4% | 24.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).